|
| Exchange Disseminated Time | Marksans Pharma Ltd has informed BSE that in order to strengthen the capital base of the Company, the Board of Directors of the Company at its meeting held August 26, 2011, has proposed to issue, subject to the approval of the shareholders and the regulatory authority as applicable 1,75,00,000 (One crore seventy five lacs only) warrants convertible into equal numbers of equity shares of Re. 1/- each to the Promoters of the Company under private placement basis at such price and under the terms and conditions in accordance with Chapter VII of the SEBI (ICDR) Regulations, 2009 as in force.
|
|
|